nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—SLC7A1—prostate cancer	0.314	0.539	CbGaD
L-Arginine—ARG2—prostate cancer	0.194	0.333	CbGaD
L-Arginine—NOS2—Doxorubicin—prostate cancer	0.0886	0.5	CbGbCtD
L-Arginine—NOS3—Doxorubicin—prostate cancer	0.0886	0.5	CbGbCtD
L-Arginine—NOS3—prostate cancer	0.0744	0.128	CbGaD
L-Arginine—NOS3—penis—prostate cancer	0.00579	0.0951	CbGeAlD
L-Arginine—SLC7A3—prostate gland—prostate cancer	0.00426	0.07	CbGeAlD
L-Arginine—AZIN2—prostate gland—prostate cancer	0.0038	0.0624	CbGeAlD
L-Arginine—ASL—prostate gland—prostate cancer	0.00353	0.058	CbGeAlD
L-Arginine—ASL—renal system—prostate cancer	0.00241	0.0395	CbGeAlD
L-Arginine—SLC7A1—prostate gland—prostate cancer	0.00231	0.038	CbGeAlD
L-Arginine—ARG2—prostate gland—prostate cancer	0.00198	0.0325	CbGeAlD
L-Arginine—SLC7A3—testis—prostate cancer	0.00188	0.0308	CbGeAlD
L-Arginine—SLC7A4—testis—prostate cancer	0.00175	0.0287	CbGeAlD
L-Arginine—AZIN2—testis—prostate cancer	0.00167	0.0275	CbGeAlD
L-Arginine—SLC7A1—renal system—prostate cancer	0.00158	0.0259	CbGeAlD
L-Arginine—ASL—testis—prostate cancer	0.00156	0.0255	CbGeAlD
L-Arginine—ARG2—epithelium—prostate cancer	0.00145	0.0239	CbGeAlD
L-Arginine—ASS1—prostate gland—prostate cancer	0.00139	0.0228	CbGeAlD
L-Arginine—NOS3—prostate gland—prostate cancer	0.00138	0.0227	CbGeAlD
L-Arginine—ARG2—renal system—prostate cancer	0.00135	0.0222	CbGeAlD
L-Arginine—ARG2—urethra—prostate cancer	0.00133	0.0218	CbGeAlD
L-Arginine—AZIN2—lymph node—prostate cancer	0.00121	0.0199	CbGeAlD
L-Arginine—ASS1—seminal vesicle—prostate cancer	0.00117	0.0193	CbGeAlD
L-Arginine—ASL—lymph node—prostate cancer	0.00113	0.0185	CbGeAlD
L-Arginine—ASS1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00113	1	CbGdCrCtD
L-Arginine—SLC7A1—testis—prostate cancer	0.00102	0.0167	CbGeAlD
L-Arginine—ASS1—epithelium—prostate cancer	0.00102	0.0167	CbGeAlD
L-Arginine—NOS3—epithelium—prostate cancer	0.00102	0.0167	CbGeAlD
L-Arginine—L-Lysine—SLC7A1—prostate cancer	0.000993	0.241	CrCbGaD
L-Arginine—SLC16A10—prostate gland—prostate cancer	0.000991	0.0163	CbGeAlD
L-Arginine—L-Cysteine—CSAD—prostate cancer	0.000966	0.234	CrCbGaD
L-Arginine—ASS1—renal system—prostate cancer	0.000946	0.0155	CbGeAlD
L-Arginine—NOS3—renal system—prostate cancer	0.000943	0.0155	CbGeAlD
L-Arginine—ASS1—urethra—prostate cancer	0.000929	0.0153	CbGeAlD
L-Arginine—SLC22A4—prostate gland—prostate cancer	0.000883	0.0145	CbGeAlD
L-Arginine—ARG2—testis—prostate cancer	0.000872	0.0143	CbGeAlD
L-Arginine—L-Ornithine—SLC7A1—prostate cancer	0.000753	0.182	CrCbGaD
L-Arginine—SLC22A4—seminal vesicle—prostate cancer	0.000747	0.0123	CbGeAlD
L-Arginine—SLC7A1—lymph node—prostate cancer	0.000739	0.0121	CbGeAlD
L-Arginine—SLC16A10—epithelium—prostate cancer	0.000728	0.012	CbGeAlD
L-Arginine—L-Glutamine—QARS—prostate cancer	0.000632	0.153	CrCbGaD
L-Arginine—ARG2—lymph node—prostate cancer	0.000632	0.0104	CbGeAlD
L-Arginine—ASS1—testis—prostate cancer	0.000611	0.01	CbGeAlD
L-Arginine—NOS3—testis—prostate cancer	0.000609	0.01	CbGeAlD
L-Arginine—SLC22A4—renal system—prostate cancer	0.000602	0.00988	CbGeAlD
L-Arginine—SLC22A5—prostate gland—prostate cancer	0.000584	0.00959	CbGeAlD
L-Arginine—Skin necrosis—Epirubicin—prostate cancer	0.000571	0.00865	CcSEcCtD
L-Arginine—Numbness—Estradiol—prostate cancer	0.000554	0.0084	CcSEcCtD
L-Arginine—Necrosis—Mitoxantrone—prostate cancer	0.000545	0.00826	CcSEcCtD
L-Arginine—Sensory loss—Estradiol—prostate cancer	0.00053	0.00803	CcSEcCtD
L-Arginine—Skin necrosis—Doxorubicin—prostate cancer	0.000528	0.00801	CcSEcCtD
L-Arginine—Haematuria—Cabazitaxel—prostate cancer	0.000518	0.00785	CcSEcCtD
L-Arginine—Hypoaesthesia—Degarelix—prostate cancer	0.000515	0.0078	CcSEcCtD
L-Arginine—SLC22A5—seminal vesicle—prostate cancer	0.000494	0.00811	CbGeAlD
L-Arginine—Extravasation—Mitoxantrone—prostate cancer	0.00049	0.00743	CcSEcCtD
L-Arginine—Hypoaesthesia—Cabazitaxel—prostate cancer	0.000485	0.00735	CcSEcCtD
L-Arginine—Platelet count decreased—Capecitabine—prostate cancer	0.000481	0.0073	CcSEcCtD
L-Arginine—Swelling—Goserelin—prostate cancer	0.000476	0.00722	CcSEcCtD
L-Arginine—Swelling—Conjugated Estrogens—prostate cancer	0.000472	0.00716	CcSEcCtD
L-Arginine—L-Ornithine—ARG2—prostate cancer	0.000465	0.113	CrCbGaD
L-Arginine—SLC22A4—bone marrow—prostate cancer	0.000455	0.00747	CbGeAlD
L-Arginine—Necrosis—Etoposide—prostate cancer	0.000453	0.00687	CcSEcCtD
L-Arginine—Flushing—Cabazitaxel—prostate cancer	0.000452	0.00686	CcSEcCtD
L-Arginine—Sweating—Bicalutamide—prostate cancer	0.000446	0.00677	CcSEcCtD
L-Arginine—Haematuria—Bicalutamide—prostate cancer	0.000444	0.00673	CcSEcCtD
L-Arginine—ASS1—lymph node—prostate cancer	0.000443	0.00727	CbGeAlD
L-Arginine—Anaphylactic shock—Estrone—prostate cancer	0.000443	0.00672	CcSEcCtD
L-Arginine—Anorexia—Estramustine—prostate cancer	0.000442	0.0067	CcSEcCtD
L-Arginine—NOS3—lymph node—prostate cancer	0.000442	0.00725	CbGeAlD
L-Arginine—Skin exfoliation—Estradiol—prostate cancer	0.000438	0.00665	CcSEcCtD
L-Arginine—SLC16A10—testis—prostate cancer	0.000437	0.00717	CbGeAlD
L-Arginine—Numbness—Etoposide—prostate cancer	0.000429	0.00651	CcSEcCtD
L-Arginine—Lethargy—Goserelin—prostate cancer	0.000429	0.0065	CcSEcCtD
L-Arginine—Sensory loss—Etoposide—prostate cancer	0.000411	0.00623	CcSEcCtD
L-Arginine—Extravasation—Etoposide—prostate cancer	0.000408	0.00618	CcSEcCtD
L-Arginine—Decreased appetite—Estramustine—prostate cancer	0.000403	0.00611	CcSEcCtD
L-Arginine—SLC22A5—renal system—prostate cancer	0.000398	0.00654	CbGeAlD
L-Arginine—Hyperhidrosis—Nilutamide—prostate cancer	0.000398	0.00603	CcSEcCtD
L-Arginine—Anorexia—Nilutamide—prostate cancer	0.000392	0.00595	CcSEcCtD
L-Arginine—SLC22A5—urethra—prostate cancer	0.000391	0.00642	CbGeAlD
L-Arginine—Anorexia—Flutamide—prostate cancer	0.00039	0.00592	CcSEcCtD
L-Arginine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.000387	0.00586	CcSEcCtD
L-Arginine—Swelling—Estradiol—prostate cancer	0.000378	0.00573	CcSEcCtD
L-Arginine—Necrosis—Docetaxel—prostate cancer	0.000377	0.00571	CcSEcCtD
L-Arginine—Anaphylactic shock—Degarelix—prostate cancer	0.000367	0.00557	CcSEcCtD
L-Arginine—Decreased appetite—Nilutamide—prostate cancer	0.000358	0.00542	CcSEcCtD
L-Arginine—Decreased appetite—Flutamide—prostate cancer	0.000356	0.0054	CcSEcCtD
L-Arginine—Hyperhidrosis—Degarelix—prostate cancer	0.000355	0.00539	CcSEcCtD
L-Arginine—Swelling—Mitoxantrone—prostate cancer	0.000352	0.00534	CcSEcCtD
L-Arginine—Hypoaesthesia—Ethinyl Estradiol—prostate cancer	0.000352	0.00533	CcSEcCtD
L-Arginine—Lethargy—Estradiol—prostate cancer	0.00034	0.00516	CcSEcCtD
L-Arginine—Skin exfoliation—Etoposide—prostate cancer	0.00034	0.00515	CcSEcCtD
L-Arginine—Extravasation—Docetaxel—prostate cancer	0.000339	0.00514	CcSEcCtD
L-Arginine—Tachycardia—Cabazitaxel—prostate cancer	0.000338	0.00512	CcSEcCtD
L-Arginine—Anorexia—Cabazitaxel—prostate cancer	0.00033	0.005	CcSEcCtD
L-Arginine—Necrosis—Prednisone—prostate cancer	0.000325	0.00493	CcSEcCtD
L-Arginine—Decreased appetite—Degarelix—prostate cancer	0.000319	0.00484	CcSEcCtD
L-Arginine—SLC16A10—lymph node—prostate cancer	0.000317	0.0052	CbGeAlD
L-Arginine—Sweating—Goserelin—prostate cancer	0.000311	0.00471	CcSEcCtD
L-Arginine—Haematuria—Goserelin—prostate cancer	0.000309	0.00468	CcSEcCtD
L-Arginine—Decreased appetite—Cabazitaxel—prostate cancer	0.000301	0.00456	CcSEcCtD
L-Arginine—Vomiting—Estramustine—prostate cancer	0.000295	0.00447	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—prostate cancer	0.000294	0.00446	CcSEcCtD
L-Arginine—Swelling—Etoposide—prostate cancer	0.000293	0.00444	CcSEcCtD
L-Arginine—Rash—Estramustine—prostate cancer	0.000292	0.00443	CcSEcCtD
L-Arginine—Dermatitis—Estramustine—prostate cancer	0.000292	0.00443	CcSEcCtD
L-Arginine—Headache—Estramustine—prostate cancer	0.00029	0.0044	CcSEcCtD
L-Arginine—Hyperhidrosis—Bicalutamide—prostate cancer	0.000287	0.00435	CcSEcCtD
L-Arginine—Hypoaesthesia—Conjugated Estrogens—prostate cancer	0.000287	0.00435	CcSEcCtD
L-Arginine—Vomiting—Abiraterone—prostate cancer	0.000286	0.00434	CcSEcCtD
L-Arginine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000285	0.00432	CcSEcCtD
L-Arginine—Injection site reaction—Capecitabine—prostate cancer	0.000285	0.00431	CcSEcCtD
L-Arginine—Rash—Abiraterone—prostate cancer	0.000284	0.0043	CcSEcCtD
L-Arginine—Dermatitis—Abiraterone—prostate cancer	0.000284	0.0043	CcSEcCtD
L-Arginine—Anorexia—Bicalutamide—prostate cancer	0.000283	0.00429	CcSEcCtD
L-Arginine—Skin exfoliation—Docetaxel—prostate cancer	0.000282	0.00428	CcSEcCtD
L-Arginine—SLC22A4—lymph node—prostate cancer	0.000282	0.00463	CbGeAlD
L-Arginine—Vomiting—Estrone—prostate cancer	0.000282	0.00427	CcSEcCtD
L-Arginine—Rash—Estrone—prostate cancer	0.000279	0.00423	CcSEcCtD
L-Arginine—Dermatitis—Estrone—prostate cancer	0.000279	0.00423	CcSEcCtD
L-Arginine—Headache—Estrone—prostate cancer	0.000277	0.00421	CcSEcCtD
L-Arginine—Nausea—Estramustine—prostate cancer	0.000275	0.00418	CcSEcCtD
L-Arginine—Skin exfoliation—Capecitabine—prostate cancer	0.000273	0.00414	CcSEcCtD
L-Arginine—Hypersensitivity—Degarelix—prostate cancer	0.000271	0.00411	CcSEcCtD
L-Arginine—Nausea—Estrone—prostate cancer	0.000263	0.00399	CcSEcCtD
L-Arginine—Vomiting—Nilutamide—prostate cancer	0.000262	0.00397	CcSEcCtD
L-Arginine—Vomiting—Flutamide—prostate cancer	0.00026	0.00395	CcSEcCtD
L-Arginine—Rash—Nilutamide—prostate cancer	0.000259	0.00393	CcSEcCtD
L-Arginine—Dermatitis—Nilutamide—prostate cancer	0.000259	0.00393	CcSEcCtD
L-Arginine—Rash—Flutamide—prostate cancer	0.000258	0.00392	CcSEcCtD
L-Arginine—Decreased appetite—Bicalutamide—prostate cancer	0.000258	0.00391	CcSEcCtD
L-Arginine—Dermatitis—Flutamide—prostate cancer	0.000258	0.00391	CcSEcCtD
L-Arginine—Headache—Nilutamide—prostate cancer	0.000258	0.00391	CcSEcCtD
L-Arginine—SLC22A5—testis—prostate cancer	0.000257	0.00422	CbGeAlD
L-Arginine—Headache—Flutamide—prostate cancer	0.000257	0.00389	CcSEcCtD
L-Arginine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000255	0.00387	CcSEcCtD
L-Arginine—Necrosis—Epirubicin—prostate cancer	0.000254	0.00385	CcSEcCtD
L-Arginine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000246	0.00373	CcSEcCtD
L-Arginine—Haematuria—Estradiol—prostate cancer	0.000245	0.00371	CcSEcCtD
L-Arginine—Nausea—Nilutamide—prostate cancer	0.000244	0.00371	CcSEcCtD
L-Arginine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000244	0.0037	CcSEcCtD
L-Arginine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000243	0.00369	CcSEcCtD
L-Arginine—Skin exfoliation—Prednisone—prostate cancer	0.000243	0.00369	CcSEcCtD
L-Arginine—Swelling—Docetaxel—prostate cancer	0.000243	0.00369	CcSEcCtD
L-Arginine—Nausea—Flutamide—prostate cancer	0.000243	0.00369	CcSEcCtD
L-Arginine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000242	0.00367	CcSEcCtD
L-Arginine—Swelling—Capecitabine—prostate cancer	0.000236	0.00357	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—prostate cancer	0.000235	0.00356	CcSEcCtD
L-Arginine—Vomiting—Degarelix—prostate cancer	0.000234	0.00354	CcSEcCtD
L-Arginine—Rash—Degarelix—prostate cancer	0.000232	0.00351	CcSEcCtD
L-Arginine—Dermatitis—Degarelix—prostate cancer	0.000231	0.00351	CcSEcCtD
L-Arginine—Headache—Degarelix—prostate cancer	0.00023	0.00349	CcSEcCtD
L-Arginine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00023	0.00348	CcSEcCtD
L-Arginine—Sweating—Mitoxantrone—prostate cancer	0.000229	0.00348	CcSEcCtD
L-Arginine—Hypoaesthesia—Estradiol—prostate cancer	0.000229	0.00348	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—prostate cancer	0.000229	0.00347	CcSEcCtD
L-Arginine—Haematuria—Mitoxantrone—prostate cancer	0.000228	0.00346	CcSEcCtD
L-Arginine—Vomiting—Cabazitaxel—prostate cancer	0.00022	0.00334	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—prostate cancer	0.000219	0.00332	CcSEcCtD
L-Arginine—Hypersensitivity—Bicalutamide—prostate cancer	0.000219	0.00332	CcSEcCtD
L-Arginine—Nausea—Degarelix—prostate cancer	0.000218	0.00331	CcSEcCtD
L-Arginine—Headache—Cabazitaxel—prostate cancer	0.000217	0.00329	CcSEcCtD
L-Arginine—Flushing—Estradiol—prostate cancer	0.000214	0.00324	CcSEcCtD
L-Arginine—Lethargy—Capecitabine—prostate cancer	0.000212	0.00322	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—prostate cancer	0.000211	0.00321	CcSEcCtD
L-Arginine—Anaphylactic shock—Goserelin—prostate cancer	0.000207	0.00313	CcSEcCtD
L-Arginine—Nausea—Cabazitaxel—prostate cancer	0.000206	0.00312	CcSEcCtD
L-Arginine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000205	0.0031	CcSEcCtD
L-Arginine—Tachycardia—Goserelin—prostate cancer	0.000202	0.00306	CcSEcCtD
L-Arginine—Hyperhidrosis—Goserelin—prostate cancer	0.0002	0.00303	CcSEcCtD
L-Arginine—Tachycardia—Conjugated Estrogens—prostate cancer	0.0002	0.00303	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—prostate cancer	0.000198	0.00301	CcSEcCtD
L-Arginine—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000198	0.003	CcSEcCtD
L-Arginine—Anorexia—Goserelin—prostate cancer	0.000197	0.00299	CcSEcCtD
L-Arginine—Anorexia—Conjugated Estrogens—prostate cancer	0.000195	0.00296	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—prostate cancer	0.00019	0.00289	CcSEcCtD
L-Arginine—L-Citrulline—NOS3—prostate cancer	0.00019	0.0459	CrCbGaD
L-Arginine—Lethargy—Prednisone—prostate cancer	0.000189	0.00286	CcSEcCtD
L-Arginine—Vomiting—Bicalutamide—prostate cancer	0.000189	0.00286	CcSEcCtD
L-Arginine—Rash—Bicalutamide—prostate cancer	0.000187	0.00284	CcSEcCtD
L-Arginine—Dermatitis—Bicalutamide—prostate cancer	0.000187	0.00284	CcSEcCtD
L-Arginine—SLC22A5—lymph node—prostate cancer	0.000187	0.00306	CbGeAlD
L-Arginine—Headache—Bicalutamide—prostate cancer	0.000186	0.00282	CcSEcCtD
L-Arginine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000185	0.0028	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—prostate cancer	0.000183	0.00278	CcSEcCtD
L-Arginine—Decreased appetite—Goserelin—prostate cancer	0.00018	0.00272	CcSEcCtD
L-Arginine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000178	0.0027	CcSEcCtD
L-Arginine—Hypoaesthesia—Etoposide—prostate cancer	0.000178	0.0027	CcSEcCtD
L-Arginine—Nausea—Bicalutamide—prostate cancer	0.000176	0.00267	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—prostate cancer	0.000176	0.00267	CcSEcCtD
L-Arginine—Flushing—Etoposide—prostate cancer	0.000166	0.00251	CcSEcCtD
L-Arginine—Anaphylactic shock—Estradiol—prostate cancer	0.000164	0.00248	CcSEcCtD
L-Arginine—Tachycardia—Estradiol—prostate cancer	0.00016	0.00242	CcSEcCtD
L-Arginine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00016	0.00242	CcSEcCtD
L-Arginine—Hyperhidrosis—Estradiol—prostate cancer	0.000158	0.0024	CcSEcCtD
L-Arginine—Rash—Ethinyl Estradiol—prostate cancer	0.000158	0.0024	CcSEcCtD
L-Arginine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000158	0.0024	CcSEcCtD
L-Arginine—Headache—Ethinyl Estradiol—prostate cancer	0.000157	0.00238	CcSEcCtD
L-Arginine—Haematuria—Capecitabine—prostate cancer	0.000153	0.00232	CcSEcCtD
L-Arginine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000153	0.00231	CcSEcCtD
L-Arginine—Hypersensitivity—Goserelin—prostate cancer	0.000152	0.00231	CcSEcCtD
L-Arginine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000151	0.00229	CcSEcCtD
L-Arginine—Nausea—Ethinyl Estradiol—prostate cancer	0.000149	0.00226	CcSEcCtD
L-Arginine—Tachycardia—Mitoxantrone—prostate cancer	0.000149	0.00226	CcSEcCtD
L-Arginine—Hypoaesthesia—Docetaxel—prostate cancer	0.000148	0.00224	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—prostate cancer	0.000148	0.00224	CcSEcCtD
L-Arginine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000148	0.00224	CcSEcCtD
L-Arginine—Anorexia—Mitoxantrone—prostate cancer	0.000145	0.00221	CcSEcCtD
L-Arginine—Hypoaesthesia—Capecitabine—prostate cancer	0.000143	0.00217	CcSEcCtD
L-Arginine—Decreased appetite—Estradiol—prostate cancer	0.000142	0.00216	CcSEcCtD
L-Arginine—Flushing—Docetaxel—prostate cancer	0.000138	0.00209	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—prostate cancer	0.000137	0.00207	CcSEcCtD
L-Arginine—Flushing—Capecitabine—prostate cancer	0.000133	0.00202	CcSEcCtD
L-Arginine—Decreased appetite—Mitoxantrone—prostate cancer	0.000133	0.00201	CcSEcCtD
L-Arginine—Vomiting—Goserelin—prostate cancer	0.000131	0.00199	CcSEcCtD
L-Arginine—Rash—Goserelin—prostate cancer	0.00013	0.00198	CcSEcCtD
L-Arginine—Dermatitis—Goserelin—prostate cancer	0.00013	0.00197	CcSEcCtD
L-Arginine—Vomiting—Conjugated Estrogens—prostate cancer	0.00013	0.00197	CcSEcCtD
L-Arginine—Headache—Goserelin—prostate cancer	0.000129	0.00196	CcSEcCtD
L-Arginine—L-Methionine—MTHFR—prostate cancer	0.000129	0.0313	CrCbGaD
L-Arginine—Rash—Conjugated Estrogens—prostate cancer	0.000129	0.00196	CcSEcCtD
L-Arginine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000129	0.00195	CcSEcCtD
L-Arginine—Headache—Conjugated Estrogens—prostate cancer	0.000128	0.00194	CcSEcCtD
L-Arginine—Anaphylactic shock—Etoposide—prostate cancer	0.000127	0.00192	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—prostate cancer	0.000124	0.00188	CcSEcCtD
L-Arginine—Nausea—Goserelin—prostate cancer	0.000123	0.00186	CcSEcCtD
L-Arginine—Hyperhidrosis—Etoposide—prostate cancer	0.000123	0.00186	CcSEcCtD
L-Arginine—Nausea—Conjugated Estrogens—prostate cancer	0.000122	0.00184	CcSEcCtD
L-Arginine—Anorexia—Etoposide—prostate cancer	0.000121	0.00183	CcSEcCtD
L-Arginine—Hypersensitivity—Estradiol—prostate cancer	0.000121	0.00183	CcSEcCtD
L-Arginine—Flushing—Prednisone—prostate cancer	0.000119	0.0018	CcSEcCtD
L-Arginine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000112	0.0017	CcSEcCtD
L-Arginine—Decreased appetite—Etoposide—prostate cancer	0.00011	0.00167	CcSEcCtD
L-Arginine—Sweating—Epirubicin—prostate cancer	0.000107	0.00162	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—prostate cancer	0.000106	0.00161	CcSEcCtD
L-Arginine—Anaphylactic shock—Docetaxel—prostate cancer	0.000105	0.0016	CcSEcCtD
L-Arginine—Vomiting—Estradiol—prostate cancer	0.000104	0.00158	CcSEcCtD
L-Arginine—Rash—Estradiol—prostate cancer	0.000103	0.00157	CcSEcCtD
L-Arginine—Dermatitis—Estradiol—prostate cancer	0.000103	0.00156	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—prostate cancer	0.000103	0.00156	CcSEcCtD
L-Arginine—Headache—Estradiol—prostate cancer	0.000103	0.00156	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—prostate cancer	0.000101	0.00152	CcSEcCtD
L-Arginine—Tachycardia—Capecitabine—prostate cancer	9.97e-05	0.00151	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—prostate cancer	9.96e-05	0.00151	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—prostate cancer	9.9e-05	0.0015	CcSEcCtD
L-Arginine—Hyperhidrosis—Capecitabine—prostate cancer	9.87e-05	0.0015	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—prostate cancer	9.84e-05	0.00149	CcSEcCtD
L-Arginine—Anorexia—Capecitabine—prostate cancer	9.74e-05	0.00148	CcSEcCtD
L-Arginine—Nausea—Estradiol—prostate cancer	9.73e-05	0.00148	CcSEcCtD
L-Arginine—Vomiting—Mitoxantrone—prostate cancer	9.7e-05	0.00147	CcSEcCtD
L-Arginine—Rash—Mitoxantrone—prostate cancer	9.62e-05	0.00146	CcSEcCtD
L-Arginine—Dermatitis—Mitoxantrone—prostate cancer	9.61e-05	0.00146	CcSEcCtD
L-Arginine—Headache—Mitoxantrone—prostate cancer	9.56e-05	0.00145	CcSEcCtD
L-Arginine—Hypersensitivity—Etoposide—prostate cancer	9.35e-05	0.00142	CcSEcCtD
L-Arginine—Flushing—Epirubicin—prostate cancer	9.29e-05	0.00141	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—prostate cancer	9.22e-05	0.0014	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—prostate cancer	9.17e-05	0.00139	CcSEcCtD
L-Arginine—Anaphylactic shock—Prednisone—prostate cancer	9.1e-05	0.00138	CcSEcCtD
L-Arginine—Nausea—Mitoxantrone—prostate cancer	9.06e-05	0.00137	CcSEcCtD
L-Arginine—Tachycardia—Prednisone—prostate cancer	8.88e-05	0.00135	CcSEcCtD
L-Arginine—Decreased appetite—Capecitabine—prostate cancer	8.88e-05	0.00135	CcSEcCtD
L-Arginine—Hyperhidrosis—Prednisone—prostate cancer	8.79e-05	0.00133	CcSEcCtD
L-Arginine—Anorexia—Prednisone—prostate cancer	8.67e-05	0.00131	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—prostate cancer	8.6e-05	0.0013	CcSEcCtD
L-Arginine—Vomiting—Etoposide—prostate cancer	8.07e-05	0.00122	CcSEcCtD
L-Arginine—Rash—Etoposide—prostate cancer	8e-05	0.00121	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—prostate cancer	8e-05	0.00121	CcSEcCtD
L-Arginine—Headache—Etoposide—prostate cancer	7.95e-05	0.00121	CcSEcCtD
L-Arginine—Decreased appetite—Prednisone—prostate cancer	7.91e-05	0.0012	CcSEcCtD
L-Arginine—Hypersensitivity—Docetaxel—prostate cancer	7.77e-05	0.00118	CcSEcCtD
L-Arginine—Nausea—Etoposide—prostate cancer	7.54e-05	0.00114	CcSEcCtD
L-Arginine—Hypersensitivity—Capecitabine—prostate cancer	7.52e-05	0.00114	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—prostate cancer	7.12e-05	0.00108	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—prostate cancer	6.94e-05	0.00105	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—prostate cancer	6.88e-05	0.00104	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—prostate cancer	6.78e-05	0.00103	CcSEcCtD
L-Arginine—Vomiting—Docetaxel—prostate cancer	6.71e-05	0.00102	CcSEcCtD
L-Arginine—Hypersensitivity—Prednisone—prostate cancer	6.7e-05	0.00102	CcSEcCtD
L-Arginine—Rash—Docetaxel—prostate cancer	6.65e-05	0.00101	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—prostate cancer	6.65e-05	0.00101	CcSEcCtD
L-Arginine—Headache—Docetaxel—prostate cancer	6.61e-05	0.001	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—prostate cancer	6.58e-05	0.000998	CcSEcCtD
L-Arginine—Vomiting—Capecitabine—prostate cancer	6.49e-05	0.000985	CcSEcCtD
L-Arginine—Rash—Capecitabine—prostate cancer	6.44e-05	0.000976	CcSEcCtD
L-Arginine—Dermatitis—Capecitabine—prostate cancer	6.43e-05	0.000976	CcSEcCtD
L-Arginine—Tachycardia—Doxorubicin—prostate cancer	6.43e-05	0.000974	CcSEcCtD
L-Arginine—Headache—Capecitabine—prostate cancer	6.4e-05	0.00097	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—prostate cancer	6.36e-05	0.000965	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—prostate cancer	6.28e-05	0.000952	CcSEcCtD
L-Arginine—Nausea—Docetaxel—prostate cancer	6.27e-05	0.00095	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—prostate cancer	6.19e-05	0.000938	CcSEcCtD
L-Arginine—Nausea—Capecitabine—prostate cancer	6.07e-05	0.00092	CcSEcCtD
L-Arginine—Vomiting—Prednisone—prostate cancer	5.78e-05	0.000877	CcSEcCtD
L-Arginine—Rash—Prednisone—prostate cancer	5.74e-05	0.00087	CcSEcCtD
L-Arginine—Dermatitis—Prednisone—prostate cancer	5.73e-05	0.000869	CcSEcCtD
L-Arginine—Decreased appetite—Doxorubicin—prostate cancer	5.72e-05	0.000868	CcSEcCtD
L-Arginine—Headache—Prednisone—prostate cancer	5.7e-05	0.000864	CcSEcCtD
L-Arginine—Nausea—Prednisone—prostate cancer	5.4e-05	0.000819	CcSEcCtD
L-Arginine—Hypersensitivity—Epirubicin—prostate cancer	5.24e-05	0.000795	CcSEcCtD
L-Arginine—Hypersensitivity—Doxorubicin—prostate cancer	4.85e-05	0.000735	CcSEcCtD
L-Arginine—Vomiting—Epirubicin—prostate cancer	4.52e-05	0.000686	CcSEcCtD
L-Arginine—Rash—Epirubicin—prostate cancer	4.49e-05	0.00068	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—prostate cancer	4.48e-05	0.00068	CcSEcCtD
L-Arginine—Headache—Epirubicin—prostate cancer	4.46e-05	0.000676	CcSEcCtD
L-Arginine—Nausea—Epirubicin—prostate cancer	4.23e-05	0.000641	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—prostate cancer	4.19e-05	0.000635	CcSEcCtD
L-Arginine—Rash—Doxorubicin—prostate cancer	4.15e-05	0.000629	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—prostate cancer	4.15e-05	0.000629	CcSEcCtD
L-Arginine—Headache—Doxorubicin—prostate cancer	4.12e-05	0.000625	CcSEcCtD
L-Arginine—Nausea—Doxorubicin—prostate cancer	3.91e-05	0.000593	CcSEcCtD
L-Arginine—NOS3—Disease—PARP1—prostate cancer	9.02e-06	8.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR4—prostate cancer	9.02e-06	8.35e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—prostate cancer	9e-06	8.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLCB2—prostate cancer	8.96e-06	8.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LRP2—prostate cancer	8.96e-06	8.3e-05	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.96e-06	8.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HPGDS—prostate cancer	8.94e-06	8.28e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—INS—prostate cancer	8.92e-06	8.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CALCA—prostate cancer	8.91e-06	8.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CD—prostate cancer	8.89e-06	8.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2C19—prostate cancer	8.88e-06	8.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SERPINE1—prostate cancer	8.79e-06	8.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—P4HB—prostate cancer	8.79e-06	8.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CX3CL1—prostate cancer	8.79e-06	8.14e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CREBBP—prostate cancer	8.73e-06	8.09e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTT1—prostate cancer	8.67e-06	8.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ACHE—prostate cancer	8.67e-06	8.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIST1H2BG—prostate cancer	8.63e-06	7.99e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	8.62e-06	7.98e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—EP300—prostate cancer	8.58e-06	7.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2A6—prostate cancer	8.57e-06	7.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDE4D—prostate cancer	8.55e-06	7.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRB7—prostate cancer	8.55e-06	7.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HSPA1A—prostate cancer	8.54e-06	7.91e-05	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—prostate cancer	8.38e-06	7.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKR1C3—prostate cancer	8.34e-06	7.72e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—LPL—prostate cancer	8.34e-06	7.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIST1H4H—prostate cancer	8.33e-06	7.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PRKACB—prostate cancer	8.29e-06	7.68e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CD—prostate cancer	8.28e-06	7.67e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PDGFRB—prostate cancer	8.26e-06	7.65e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—prostate cancer	8.23e-06	7.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP17A1—prostate cancer	8.21e-06	7.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CASP9—prostate cancer	8.19e-06	7.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—JAK2—prostate cancer	8.16e-06	7.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNG5—prostate cancer	8.13e-06	7.53e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—prostate cancer	8e-06	7.41e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERCC2—prostate cancer	7.98e-06	7.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PRKCQ—prostate cancer	7.94e-06	7.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOA2—prostate cancer	7.82e-06	7.24e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NOS3—prostate cancer	7.82e-06	7.24e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB3—prostate cancer	7.81e-06	7.23e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR2—prostate cancer	7.8e-06	7.22e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—prostate cancer	7.79e-06	7.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CB—prostate cancer	7.75e-06	7.18e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—prostate cancer	7.66e-06	7.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF10—prostate cancer	7.54e-06	6.99e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—prostate cancer	7.51e-06	6.95e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—prostate cancer	7.48e-06	6.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—prostate cancer	7.46e-06	6.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2E1—prostate cancer	7.29e-06	6.75e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—prostate cancer	7.22e-06	6.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NQO1—prostate cancer	7.21e-06	6.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFBR2—prostate cancer	7.18e-06	6.65e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—prostate cancer	7.16e-06	6.63e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—prostate cancer	7.15e-06	6.62e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—prostate cancer	7.15e-06	6.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—prostate cancer	7.12e-06	6.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TH—prostate cancer	7.1e-06	6.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR1—prostate cancer	7.09e-06	6.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTHLH—prostate cancer	7.09e-06	6.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ITPR1—prostate cancer	7.06e-06	6.54e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP3A4—prostate cancer	7.03e-06	6.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKR1C3—prostate cancer	6.97e-06	6.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKACB—prostate cancer	6.93e-06	6.42e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CAV1—prostate cancer	6.92e-06	6.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1B1—prostate cancer	6.91e-06	6.4e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.85e-06	6.34e-05	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—prostate cancer	6.84e-06	6.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP3CA—prostate cancer	6.76e-06	6.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—THBS1—prostate cancer	6.76e-06	6.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GGT1—prostate cancer	6.69e-06	6.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ANXA1—prostate cancer	6.66e-06	6.17e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—prostate cancer	6.62e-06	6.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOA1—prostate cancer	6.59e-06	6.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCZ—prostate cancer	6.54e-06	6.06e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—BAD—prostate cancer	6.51e-06	6.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP19A1—prostate cancer	6.49e-06	6.02e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—LPL—prostate cancer	6.47e-06	5.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PDGFRB—prostate cancer	6.41e-06	5.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—prostate cancer	6.39e-06	5.91e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—prostate cancer	6.35e-06	5.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR4—prostate cancer	6.32e-06	5.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PARP1—prostate cancer	6.32e-06	5.85e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—APC—prostate cancer	6.31e-06	5.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—RXRA—prostate cancer	6.27e-06	5.81e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—prostate cancer	6.26e-06	5.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALCA—prostate cancer	6.24e-06	5.78e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—prostate cancer	6.24e-06	5.78e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGF—prostate cancer	6.23e-06	5.77e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IRS1—prostate cancer	6.23e-06	5.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—prostate cancer	6.21e-06	5.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERCC2—prostate cancer	6.2e-06	5.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL12—prostate cancer	6.09e-06	5.64e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—prostate cancer	6.08e-06	5.63e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB3—prostate cancer	6.06e-06	5.62e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR2—prostate cancer	6.05e-06	5.61e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—GSK3B—prostate cancer	6.05e-06	5.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—prostate cancer	6.05e-06	5.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—COMT—prostate cancer	6.04e-06	5.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—prostate cancer	6.01e-06	5.57e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—INS—prostate cancer	5.97e-06	5.53e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—prostate cancer	5.95e-06	5.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ITPR1—prostate cancer	5.91e-06	5.48e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—prostate cancer	5.89e-06	5.45e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CREBBP—prostate cancer	5.85e-06	5.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—prostate cancer	5.83e-06	5.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—prostate cancer	5.81e-06	5.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP9—prostate cancer	5.74e-06	5.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—prostate cancer	5.59e-06	5.17e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAP2K1—prostate cancer	5.58e-06	5.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCQ—prostate cancer	5.56e-06	5.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NGFR—prostate cancer	5.56e-06	5.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—prostate cancer	5.56e-06	5.15e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—prostate cancer	5.55e-06	5.14e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—prostate cancer	5.54e-06	5.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—prostate cancer	5.52e-06	5.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAP3K7—prostate cancer	5.49e-06	5.09e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SERPINE1—prostate cancer	5.48e-06	5.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—LPL—prostate cancer	5.42e-06	5.02e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CAV1—prostate cancer	5.38e-06	4.98e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGF2—prostate cancer	5.31e-06	4.92e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF10—prostate cancer	5.28e-06	4.89e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1A1—prostate cancer	5.24e-06	4.85e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS3—prostate cancer	5.23e-06	4.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADRB2—prostate cancer	5.23e-06	4.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ERCC2—prostate cancer	5.19e-06	4.81e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—prostate cancer	5.19e-06	4.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—prostate cancer	5.14e-06	4.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VAV3—prostate cancer	5.1e-06	4.72e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAK2—prostate cancer	5.09e-06	4.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—BAD—prostate cancer	5.06e-06	4.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR2—prostate cancer	5.03e-06	4.65e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—prostate cancer	4.97e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MDM2—prostate cancer	4.97e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ITPR1—prostate cancer	4.94e-06	4.58e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—prostate cancer	4.9e-06	4.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APC—prostate cancer	4.9e-06	4.53e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—prostate cancer	4.88e-06	4.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGF—prostate cancer	4.84e-06	4.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IRS1—prostate cancer	4.84e-06	4.48e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—prostate cancer	4.83e-06	4.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARA—prostate cancer	4.79e-06	4.43e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—prostate cancer	4.79e-06	4.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1R—prostate cancer	4.73e-06	4.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—prostate cancer	4.72e-06	4.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—GSK3B—prostate cancer	4.7e-06	4.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—INS—prostate cancer	4.64e-06	4.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—prostate cancer	4.57e-06	4.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CREBBP—prostate cancer	4.54e-06	4.2e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1B—prostate cancer	4.53e-06	4.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LPL—prostate cancer	4.53e-06	4.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAV1—prostate cancer	4.5e-06	4.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDGFRB—prostate cancer	4.49e-06	4.16e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—prostate cancer	4.4e-06	4.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ITGB3—prostate cancer	4.38e-06	4.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAP2K1—prostate cancer	4.33e-06	4.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—prostate cancer	4.3e-06	3.99e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—prostate cancer	4.28e-06	3.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SERPINE1—prostate cancer	4.26e-06	3.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB3—prostate cancer	4.25e-06	3.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR2—prostate cancer	4.24e-06	3.93e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—prostate cancer	4.18e-06	3.88e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—prostate cancer	4.18e-06	3.87e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF2—prostate cancer	4.12e-06	3.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—prostate cancer	4.1e-06	3.8e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—prostate cancer	4.07e-06	3.77e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—prostate cancer	3.98e-06	3.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAK2—prostate cancer	3.95e-06	3.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—prostate cancer	3.89e-06	3.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—INS—prostate cancer	3.88e-06	3.59e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—prostate cancer	3.87e-06	3.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—prostate cancer	3.86e-06	3.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MDM2—prostate cancer	3.86e-06	3.57e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CREBBP—prostate cancer	3.8e-06	3.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—prostate cancer	3.8e-06	3.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—LEP—prostate cancer	3.8e-06	3.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CAV1—prostate cancer	3.76e-06	3.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—prostate cancer	3.75e-06	3.47e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—prostate cancer	3.73e-06	3.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—prostate cancer	3.72e-06	3.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—prostate cancer	3.72e-06	3.44e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—prostate cancer	3.63e-06	3.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—prostate cancer	3.6e-06	3.34e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—prostate cancer	3.59e-06	3.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BAD—prostate cancer	3.54e-06	3.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1B—prostate cancer	3.52e-06	3.26e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—prostate cancer	3.47e-06	3.21e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—prostate cancer	3.46e-06	3.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—prostate cancer	3.43e-06	3.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APC—prostate cancer	3.43e-06	3.18e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—prostate cancer	3.39e-06	3.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IRS1—prostate cancer	3.39e-06	3.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGF—prostate cancer	3.39e-06	3.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—prostate cancer	3.33e-06	3.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GSK3B—prostate cancer	3.29e-06	3.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—prostate cancer	3.25e-06	3.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—INS—prostate cancer	3.25e-06	3.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—prostate cancer	3.24e-06	3e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—prostate cancer	3.21e-06	2.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CREBBP—prostate cancer	3.18e-06	2.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—prostate cancer	3.14e-06	2.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—prostate cancer	3.14e-06	2.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—prostate cancer	3.11e-06	2.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—prostate cancer	3.09e-06	2.86e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAP2K1—prostate cancer	3.03e-06	2.81e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—prostate cancer	3.01e-06	2.79e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—prostate cancer	3.01e-06	2.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SERPINE1—prostate cancer	2.98e-06	2.76e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—prostate cancer	2.95e-06	2.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—prostate cancer	2.9e-06	2.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF2—prostate cancer	2.89e-06	2.67e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAK2—prostate cancer	2.77e-06	2.56e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—prostate cancer	2.72e-06	2.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MDM2—prostate cancer	2.7e-06	2.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—prostate cancer	2.69e-06	2.5e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—prostate cancer	2.69e-06	2.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—prostate cancer	2.66e-06	2.47e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—prostate cancer	2.64e-06	2.44e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—prostate cancer	2.63e-06	2.43e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—prostate cancer	2.61e-06	2.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—prostate cancer	2.59e-06	2.4e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—prostate cancer	2.52e-06	2.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—prostate cancer	2.49e-06	2.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1B—prostate cancer	2.47e-06	2.28e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—prostate cancer	2.42e-06	2.24e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—prostate cancer	2.41e-06	2.23e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—prostate cancer	2.41e-06	2.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—prostate cancer	2.35e-06	2.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—prostate cancer	2.33e-06	2.16e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—prostate cancer	2.29e-06	2.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—prostate cancer	2.28e-06	2.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—prostate cancer	2.28e-06	2.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—prostate cancer	2.27e-06	2.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—prostate cancer	2.17e-06	2.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—prostate cancer	2.11e-06	1.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—prostate cancer	2.05e-06	1.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—prostate cancer	2.03e-06	1.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—prostate cancer	2.03e-06	1.88e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—prostate cancer	1.92e-06	1.77e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—prostate cancer	1.89e-06	1.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—prostate cancer	1.88e-06	1.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—prostate cancer	1.87e-06	1.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—prostate cancer	1.85e-06	1.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—prostate cancer	1.74e-06	1.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—prostate cancer	1.6e-06	1.48e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—prostate cancer	1.56e-06	1.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—prostate cancer	1.55e-06	1.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—prostate cancer	1.42e-06	1.31e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—prostate cancer	1.31e-06	1.21e-05	CbGpPWpGaD
